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clinical case report
46,XX Male – Testicular Disorder of 
Sexual Differentiation (DSD): hormonal, 
molecular and cytogenetic studies
Homem 46,XX (DSD testicular): estudos 
hormonal, molecular e citogenético
Cresio Alves1, Zilda Braid1, Fernanda Borchers Coeli2,  
Maricilda Palandi de Mello2
SUMMARY
The XX male syndrome – Testicular Disorder of Sexual Differentiation (DSD) is a rare condition 
characterized by a spectrum of clinical presentations, ranging from ambiguous to normal male 
genitalia. We report hormonal, molecular and cytogenetic evaluations of a boy presenting with 
this syndrome. Examination of the genitalia at age of 16 months, showed: penis of 3.5 cm, proxi-
mal hypospadia and scrotal testes. Pelvic ultrasound did not demonstrate Mullerian duct struc-
tures. Karyotype was 46,XX. Gonadotrophin stimulation test yielded insufficient testosterone 
production. Gonadal biopsy showed seminiferous tubules without evidence of Leydig cells. 
Molecular studies revealed that SRY and TSPY genes and also DYZ3 sequences were absent. In 
addition, the lack of deletions or duplications of SOX9, NR5A1, WNT4 and NROB1 regions was 
verified. The infant was heterozygous for all microsatellites at the 9p region, including DMRT1 
gene, investigated. Only 10% of the patients are SRY-negative and usually they have ambiguous 
genitalia, as the aforementioned patient. The incomplete masculinization suggests gain of func-
tion mutation in one or more genes downstream to SRY gene. Arq Bras Endocrinol Metab. 2010;54(8):685-9
SUMÁRIO
A síndrome do homem XX é uma condição rara na qual o fenótipo da genitália externa pode 
variar de uma genitália ambígua até uma genitália masculina normal. Este estudo tem por obje-
tivo relatar a avaliação hormonal, molecular e citogenética de um menino com essa síndrome. 
O exame da genitália externa na idade de 16 meses mostrava: pênis medindo 3,5 cm, hipos-
padia proximal e testículos tópicos. A ultrassonografia pélvica não visualizou estruturas mulle-
rianas. Cariótipo foi 46,XX. A testosterona sérica não se elevou após o teste de estímulo com 
gonadotrofina. Biópsias gonadais mostraram túbulos seminíferos, sem evidência de células 
de Leydig. Estudos moleculares revelaram ausência dos genes SRY, TSPY e DYZ3, bem como 
ausência de deleção ou duplicação das regiões SOX9, NR5A1, WNT4 e NROB1. A criança era he-
terozigótica para todos os microssatélites da região 9p, incluindo o gene DMRT1. Apenas 10% 
dos pacientes com a síndrome do homem 46,XX são SRY-negativos. Nesses casos, a genitália 
geralmente é ambígua, como corroborado pelo paciente do presente relato. A masculinização 
incompleta sugere ganho de mutação funcional em um ou mais genes a jusante do gene SRY. 
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INTRODUCTION
The XX male syndrome (OMIM ID #400045), now termed Testicular DSD (Testicular Disorder of 
Sexual Differentiation), was first described by La Cha-
pelle and cols. in 1964 (1). It is a rare condition, with a 
frequency of 1:20,000-25,000 male newborns (1-3). It 
is characterized by a male phenotype with 46,XX karyo-
type (1-3). The SRY gene (sex-determining region on 
the Y), which is located in the Y chromosome, plays 
an important role in the process of sex determination 
(4,5). On basis of the analysis and detection of SRY 
gene, 46, XX male patients can be clinically divided into 
SRY-positive and the SRY-negative groups (6,7). SRY-
positive individuals usually have normal male genitalia, 
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small azoospermic testes and hypergonadotropic hypo-
gonadism (8), and most carry the SRY gene translocat-
ed to the X chromosome during paternal meiosis (7,9); 
however, SRY autosomal translocations have also been 
reported in some XX males (10-12). The diagnosis of 
SRY-positive patients is usually achieved in adulthood 
during infertility investigation (3). The group of SRY-
negative (OMIM ID 278850) includes patients with 
Ovotesticular-DSD, which is characterized by the pres-
ence of both testicular and ovarian tissue in the gonads 
of the same individual (13,14), and Testicular-DSD 
characterized by a full development of both gonads as 
testes without any evidence of ovarian tissue (2). The 
occurrence of both Ovotesticular and Testicular-DSD 
in families, especially in identical twins, indicates them 
as different manifestations of the same disorder of go-
nadal development (15-17). In the absence of SRY 
gene, the up-regulation or super-expression of some 
members of SOX family (Sry-related HMG-box) have 
been proposed as involved in XX male etiology (18-
20). The diagnosis of SRY-negative testicular-DSD can 
be done in childhood upon investigation of ambiguous 
genitalia and gynecomastia. 
The aim of this study was to analyze the case of a 
boy with XX male syndrome, emphasizing its hormon-
al, molecular and cytogenetic aspects. 
CASE REPORT
A 16-month-old infant was referred to endocrine eval-
uation in our service. The mother reported that fetal 
sonograms between the 3rd-6th months of gestational 
age were compatible with a female fetus, while at the 
7th month the diagnosis was compatible with a male 
fetus with hypospadia. There were absence of endocri-
nopathies and hormonal exposure during pregnancy, 
no history of genetic syndromes, ambiguous genitalia 
or precocious neonatal death in the family. Parents are 
not consanguineous and his 5 years-old sister is healthy. 
On physical examination: weight: 10.2 kg (P. 10 - P. 
25), length: 73.5 cm (< P. 5%). The penile length was 
3.5 cm with a proximal hypospadia, both testes were 
normally located (with a more hypoplastic left testicle) 
and absent pubarche. Karyotype with G band: 46,XX. 
Neonatal screening, including 17-hydroxyprogesterone 
evaluation was normal. Pelvic ultrasound: no evidence of 
Mullerian duct structures. Gonadal biopsy: seminiferous 
tubules lined by small cuboidal cells, without evidence 
of Leydig cells. 
MATERIALS AND METHODS
The hormonal studies were performed with the human 
chorionic gonadotrophin stimulation tests (beta-hCG) 
measuring total testosterone, before and after the ad-
ministration of three doses of beta-hCG (4,500 IU, in-
tramuscularly, every other day).
Molecular studies were performed after DNA ex-
traction from peripheral blood, that followed standard 
techniques (21). Y-chromosome sequence analysis was 
conducted by PCR and nested-PCR. SRY gene was am-
plified with primers depicted in table 1, which also de-
scribes those primers used in the first and in the second 
rounds of nested-PCR for the TSPY gene and for the 
Y-centromeric region DYZ3. After PCR amplification, 
reaction products (10 ml) were submitted to 2% agarose 
gel electrophoresis with a molecular weight marker and 
stained with ethidium bromide. Each PCR reaction con-
tained normal female and male controls. Nested-PCR 
experiments contained also a template-free sample. Hap-
loinsuficiency of DMRT1 gene was evaluated with mic-
rosatellites mapping within the criptical interval 9p24.3 
according to Calvari and cols. (22), Guioli and cols. (23) 
and Veitia and cols. (24) (Table 2). MLPA assay was 
performed using SALSA MLPA P185 Intersex probe-
mix (MRC-Holland) following provider instructions. 
46,XX male: molecular studies
Table 1. Primer sequences for PCR and nested-PCR of the Y chromosome
Gene Forward Primer 5’ → 3’ Reverse Primer 5’ → 3’ Size (bp)
SRY CAT TGT CGA CCA GTG TGT 
TGA AAC GGG AGA AAA CA
CAT TGT CGA CGT ACA ACC CTG TTG 
TCC AGT TGC
380
TSPY JA 56/52 CAT GAC ATA ATG GCG GAG CGA TAG GCC TCC ACT TCA TA 1300
TSPY JA 35/30* CCC CAC CTA GAC CGC AGA GG GGG AAG AAG GCC TAA GAG CAC C 608
DYZ3 A/B TGA AAA CTA CAC AG- AAG CTG ACA CAT CAC AAA GAA CTA TG 1100
DYZ3 G/H* AGC CTT TTG TGG CCT ACG ATC CTC CTG GAG ATA CCA 330
* Internal primers for nested-PCR.
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Each MLPA reaction was analyzed on an ABI 310 Ge-
netic Analyzer (ABI PRISM/PE Biosystems, Foster 
City, CA, USA) and results were evaluated using Ge-
nescan and Genotyper softwares (Applied Biosystems, 
Foster City, CA, USA). The probemix included in the 
MLPA kit contains probes for SOX9 gene and its flank-
ing region at 17q24.3, NR5A1 gene (SF-1) at 9q33, 
WNT4 (1p36.12), NR0B1 gene (DAX-1) at Xp21.2 
and, also, control probes mapping within other regions 
on X and Y chromosomes. Data were analyzed using 
free Coffalyser MLPA data analysis software available 
in the provider website (www.mrc-holland.com). Data 
were normalized with results of five control individuals 
and with internal controls (reference probes). Normal-
ized relative values ranging within a confidence interval 
of 0.8 to 1.3, which was established by control data 
variations, corresponded to two gene copies in the gen-
otype, whereas values below 0.8 and above 1.3 would 
correspond to deletion (one gene copy) and duplica-
tion (three gene copies), respectively.
This paper was submitted to the Institutional Re-
view Board of our Institution, which approved its ethi-
cal aspects.
Table 3. Human chorionic gonadotrophin stimulation test at the 
chronological age of 16 months
Time
Hormonal evaluation
LH FSH Total testosterone
Baseline < 0,07 UI/mL 
(normal < 14 UI/L)
< 0,3 UI/mL 
(normal < 10 UI/L)
12 ng/dL  
(normal < 40 ng/dL)
Post- 
-stimulation
 40 ng/dL  
(normal > 150 ng/dL)
FSH: follicle-stimulating hormone; LH: luteinizing hormone.
RESULTS
The hormonal studies yielded low serum levels of free 
testosterone before and after the beta-hCG stimulation 
test suggesting a deficient testicular production (Table 3). 
Molecular analyses demonstrated absence of both 
SRY and TSPY genes and also Y-centromeric DYZ3 
sequence indicating absence of Y-chromosome-derived 
sequences in the genotype. The infant was heterozygous 
for all 9p microsatellites indicating haplosufficiency 
for DMRT1 gene. Deletions or duplications of genes 
involved in sex differentiation processes were investigated 
by MLPA analysis. Normal copy number for all genes 
can be observed in figure 1. Absence of Y-chromosome 
Figure 1. MLPA analysis. Integrated and normalized MLPA data for genes: SOX9 (17q24.3), NR5A1 (9p33), WNT4 (1p36.12) and NR0B1 (Xp21.2). Genes 
or gene regions are indicated below each bar in the graphic; e = exon. Chromosome regions are delimitated by black horizontal bars. Absence of signals for 
both UTY region and SRY gene probes on the Y chromosome is observed. The height of vertical bars corresponds to integrated and normalized peak areas 
obtained in capillary electrophoresis; values between 0.8 and 1.3 indicate two copies of the fragment.
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Table 2. Primer sequences utilized for the 9p microsatellite studies
Marker Size (pb) Primer Sense Primer Antissense %
D9S1779 120 – 144 CCCTGCCAGGTGTGCATCTG TCAGGCTCCCTCGTGGCTCT 63
D9S1858 236 – 248 TGCACTGTCCTGCCAAG CCCAGACTCAGATTTCCCA 58
D9S143 111 CCAAAAATGATGACTACATCC GCAACAACAAAAATGAACACT 54
D9S1813 226 – 264 GGGCCTGGCACTTAATAC AATGGCCTAAATAAAACCTGG 83
D9S54 110-121 GAAAGTCCAGAACTAAGTAG TGTGGATAGGTATATATAGC ?
% = percentage of heterozygous estimated for this locus. 
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probe signals can also be noted confirming PCR assays. 
Therefore, MLPA did not show any copy number 
variation for either SOX9, NR5A1 (SF-1), WNT4 or 
DAX-1, which is coded by NR0B1 gene. 
DISCUSSION
About 90% of 46,XX (testicular DSD) men are SRY 
gene carriers. In most cases this gene is translocated to 
the short arm-end of the paternal X chromosome (1,3). 
Therefore the mechanism generating this syndrome in 
SRY carriers involves mainly a mistake in the cross-over 
between pseudoautosomal regions of sexual chromo-
somes during the paternal meiosis (10,18). However, 
10% of the patients are SRY-negative (1,3). Molecular 
analysis in our patient showed absence of SRY, which is 
an unusual form of the XX male syndrome.
It has been considered that, in the absence of a 
functional SRY protein, male phenotype can also be 
induced in 46,XX individuals by excessive or absent ac-
tions of other determinants within the sexual differen-
tiation cascade such as SOX9, DAX-1, Ad4BP/SF-1, 
WT1, GATA4, WNT4, FGF9 and RSPO1 (10,18). In 
the patient described here, there was no evidence for 
SOX9, SF-1, WNT4 and DAX-1 duplications or dele-
tions that were investigated by MLPA technique.
In general, 46,XX male presents with three pheno-
types: normal internal and external genitalia; ambiguous 
genitalia; and, ovotesticular DSD (1-3). All are charac-
terized by infertility caused by absence of the region 
AZF present in the long arm of the Y chromosome (1-
3). In the classical presentation, 46,XX males are found 
with normal penile length, infertility and presence of 
Wolff duct structures without Mullerian duct structures 
(18). There is a higher prevalence of microrchidism and 
gynecomastia and a trend to female pubic hair distribu-
tion, with decreased facial hair (1,10). Short stature can 
occur due to absence of either pubertal spurt depen-
dent on testosterone or Y-chromosome genes related 
to specific growth forms.
Most SRY-positive patients have normal external 
genitalia, whereas SRY-negative patients are found 
within a large spectrum of masculinization ranging 
from ambiguous to normal genitalia (1,3). The diag-
nosis of the patient reported here was performed dur-
ing childhood due to ambiguous genitalia. Ovotesticu-
lar DSD, an important differential diagnosis, was ruled 
out in the patient after gonadal biopsy. During puberty, 
testosterone levels are normal evolving, in adulthood, 
to hypergonadotrophic hypogonadism (6,7,10,15,18). 
Some authors evidenced a deficient testosterone pro-
duction after β-hCG stimulation test; whereas, others 
reported a normal testosterone production by the Ley-
dig cells, although not ruling out the possibility of a 
testosterone deficiency during adulthood (3,10).
In conclusion, the SRY-negative XX male incom-
plete masculinization in this case cannot be attributed 
to SOX9, SF-1, WNT4 and DAX-1 duplications or de-
letions, however, gain of function mutations in one or 
more genes downstream the SRY gene pathway or a 
loss of function in some gene associated with the inhi-
bition of male development should be considered for 
further investigation.
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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